• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION SD ALARIS SYSTEM; PUMP, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION SD ALARIS SYSTEM; PUMP, INFUSION Back to Search Results
Model Number 8100
Device Problems Excess Flow or Over-Infusion (1311); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypoglycemia (1912); Lethargy (2560)
Event Date 12/11/2022
Event Type  Injury  
Manufacturer Narrative
Bd technical support troubleshoot with customer over the phone.The event logs have been received and the evaluation is pending.A follow up report will be submitted with investigation results once the evaluation has been completed.Per 803.52(f)(11)(iii) the information provided represents all of the known information at this time.The complainant or reporter was unable or unwilling to provide any further patient, product, or procedural details to the manufacturer.No devices received, log" review only.".
 
Event Description
It was reported an over infusion event involving insulin on a patient who was admitted to the hospital for diabetic ketoacidosis.Insulin (100ml bag, concentration 1unit/ml) was intended to infuse at 0.1units/kg/hr.(5.3ml/hr.) as a continuous infusion and was programmed manually using guardrails drug library.It was reported that the 100ml bag appeared to have been infused in 2.5 hours instead.Due to the event, rapid response team was called due to the declining blood glucose and lethargy.Patient reportedly received dextrose 10% intravenously (several doses), dextrose 50% bolus, 3% normal saline, calcium gluconate, and supplemental oxygen due to decreasing oxygen saturation.It was reported that additional lab tests were performed to frequently check blood glucose levels, comprehensive metabolic panel, and blood gas levels.It was reported that after the event and treatments, the patient was transitioned to "normal diabetic treatment and ultimately discharged home.".
 
Manufacturer Narrative
It was determined through investigation of the device logs that the initially reported suspect device with serial number# (b)(6) is a concomitant and this file has captured the correct suspect device with serial number# (b)(6) as per investigation report.Omit : c20 - no findings available, d15 - cause not established.A device history record review is performed on each device reported in a mdr reportable event along with other methods of investigation as coded in section h6 of this mdr report.
 
Event Description
It was reported an over infusion event involving insulin on a patient who was admitted to the hospital for diabetic ketoacidosis.Insulin (100ml bag, concentration 1unit/ml) was intended to infuse at 0.1units/kg/hr.(5.3ml/hr.) as a continuous infusion and was programmed manually using guardrails drug library.It was reported that the 100ml bag appeared to have been infused in 2.5 hours instead.Due to the event, rapid response team was called due to the declining blood glucose and lethargy.Patient reportedly received dextrose 10% intravenously (several doses), dextrose 50% bolus, 3% normal saline, calcium gluconate, and supplemental oxygen due to decreasing oxygen saturation.It was reported that additional lab tests were performed to frequently check blood glucose levels, comprehensive metabolic panel, and blood gas levels.It was reported that after the event and treatments, the patient was transitioned to "normal diabetic treatment and ultimately discharged home.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS SYSTEM
Type of Device
PUMP, INFUSION
Manufacturer (Section D)
CAREFUSION SD
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
brett wilko
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key16119986
MDR Text Key306880133
Report Number2016493-2022-246821
Device Sequence Number1
Product Code FRN
UDI-Device Identifier10885403810015
UDI-Public(01)10885403810015
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133532
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date 02/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number8100
Device Catalogue Number8100 ALARIS LVP MODULE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/29/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
8015; 8100(3); 8110
Patient Outcome(s) Required Intervention;
Patient Age17 YR
Patient SexMale
Patient Weight53 KG
-
-